(Q43833289)

27 November 2017

title

Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose (English)

1 reference

27 November 2017

1 reference

Hung-Chun Chen

1

1 reference

27 November 2017

Jinn-Yuh Guh

series ordinal

2

1 reference

27 November 2017

Shyi-Jang Shin

series ordinal

3

1 reference

27 November 2017

Yung-Hsiung Lai

series ordinal

4

1 reference

27 November 2017

language of work or name

1 reference

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

160

1 reference

27 November 2017

issue

1

1 reference

27 November 2017

page(s)

141-146

1 reference

Decreased Albuminuria by Pravastatin in Hyperlipidemic Diabetics

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Mechanism of preventive effect of HMG-CoA reductase inhibitor on diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

The many masks of focal segmental glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Reactive oxygen species enhances endothelin-1 production of diabetic rat glomeruli in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Oxidative modification of low-density lipoprotein enhances mesangial cell protein synthesis and gene expression of extracellular matrix proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Induction of heat shock protein 70 protects mesangial cells against oxidative injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Recombinant human erythropoietin enhances superoxide production by FMLP-stimulated polymorphonuclear leukocytes in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Native and oxidized low-density lipoproteins enhance superoxide production from diabetic rat glomeruli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Total radical-trapping antioxidant parameter in NIDDM patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Selective inhibition of formyl-methionyl-leucyl-phenylalanine (fMLF)-dependent superoxide generation in neutrophils by pravastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Fibronectin augments monocyte adhesion to low-density lipoprotein-stimulated mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Effect of pravastatin on type IV collagen secretion and mesangial cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Interaction of native and oxidized lipoprotein(a) with human mesangial cells and matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Effect of pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Lovastatin inhibits proliferation of rat mesangial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

Regulation of the mevalonate pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900545-7

10.1016/S0021-9150(01)00545-7

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference